Showing 501-508 of 508 for: Cochrane Systematic Reviews > Infectious disease 
- Vitamin C for preventing and treating the common cold
Cochrane Systematic Reviews, 31-Jan-2013
Vitamin C (ascorbic acid) for preventing and treating the common cold has been a subject of controversy for 70 years.
- Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases
Cochrane Systematic Reviews, 9-Jun-2015
Upper gastrointestinal bleeding is one of the most frequent causes of morbidity and mortality in the course of liver cirrhosis. Several treatments are used for upper gastrointestinal bleeding in people with liver diseases. One of them is vitamin K adminis
- Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries
Cochrane Systematic Reviews, 14-Aug-2012
Voluntary counseling and testing (VCT) continues to play a critical role in HIV prevention, care and treatment. In recent years, different modalities of VCT have been implemented, including clinic-, mobile- and home-based testing and counseling. This revi
- Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia
Cochrane Systematic Reviews, 24-Feb-2014
Opportunistic fungal infections are a major cause of morbidity and mortality in neutropenic cancer patients and antifungal therapy is used both empirically and therapeutically in these patients.
- Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Cochrane Systematic Reviews, 24-Jul-2000
Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. The next two drugs to be developed were didanosine (ddI) and zalcitabine (ddC).
- Zinc for the common cold
Cochrane Systematic Reviews, 17-Sep-2016
The common cold is one of the most widespread illnesses and is a leading cause of visits to the doctor and absence from school and work. Trials conducted in high-income countries since 1984 investigating the role of zinc for the common cold symptoms have
- Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
Cochrane Systematic Reviews, 5-Oct-2011
Diarrhoeal disorders and acute respiratory infections (ARIs), especially pneumonia, are the most common causes of death in low-income countries. Studies evaluating the impact of zinc supplementation as an adjunct in the management of pneumonia are limited
- Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
Cochrane Systematic Reviews, 4-Dec-2016
Pneumonia is a leading cause of morbidity and mortality in children younger than five years of age. Most deaths occur during infancy and in low-income countries. Daily zinc supplements have been reported to prevent acute lower respiratory tract infection
